CLINICAL SUPPLY MANAGEMENT ARTICLES
Root Causes, Part 1: When Trial Design Locks In Supply Risk
This first installment of our new Root Causes video series examines how decisions made long before execution can shape clinical supply outcomes.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Gain insight into why pharma companies generally seek IRT vendor relationships to ensure high-quality builds that meet their needs and avoid the potential pitfalls associated with RTSM.
-
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
As technology continues to evolve, learn how IRT systems can no longer be implemented into the fabric of the organization, but rather need to ebb and flow with the needs of clinical trials.
-
Explore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.
-
Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.
-
Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.